BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shih DQ, Targan SR. Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 2008; 14(3): 390-400 [PMID: 18200661 DOI: 10.3748/wjg.14.390] [Cited by in CrossRef: 115] [Cited by in F6Publishing: 119] [Article Influence: 8.2] [Reference Citation Analysis]
Number Citing Articles
1 Guan Q, Weiss CR, Qing G, Ma Y, Peng Z. An IL-17 peptide-based and virus-like particle vaccine enhances the bioactivity of IL-17 in vitro and in vivo. Immunotherapy 2012;4:1799-807. [PMID: 23240747 DOI: 10.2217/imt.12.129] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
2 Alagón Fernández Del Campo P, De Orta Pando A, Straface JI, López Vega JR, Toledo Plata D, Niezen Lugo SF, Alvarez Hernández D, Barrientos Fortes T, Gutiérrez-Kobeh L, Solano-Gálvez SG, Vázquez-López R. The Use of Probiotic Therapy to Modulate the Gut Microbiota and Dendritic Cell Responses in Inflammatory Bowel Diseases. Med Sci (Basel) 2019;7:E33. [PMID: 30813381 DOI: 10.3390/medsci7020033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Moussa L, Bézirard V, Salvador-Cartier C, Bacquié V, Lencina C, Lévêque M, Braniste V, Ménard S, Théodorou V, Houdeau E. A low dose of fermented soy germ alleviates gut barrier injury, hyperalgesia and faecal protease activity in a rat model of inflammatory bowel disease. PLoS One 2012;7:e49547. [PMID: 23166707 DOI: 10.1371/journal.pone.0049547] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
4 Guan Q, Moreno S, Qing G, Weiss CR, Lu L, Bernstein CN, Warrington RJ, Ma Y, Peng Z. The role and potential therapeutic application of myeloid-derived suppressor cells in TNBS-induced colitis. J Leukoc Biol. 2013;94:803-811. [PMID: 23901119 DOI: 10.1189/jlb.0113050] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
5 Hov JR, Boberg KM, Karlsen TH. Autoantibodies in primary sclerosing cholangitis. World J Gastroenterol 2008; 14(24): 3781-3791 [PMID: 18609700 DOI: 10.3748/wjg.14.3781] [Cited by in CrossRef: 90] [Cited by in F6Publishing: 74] [Article Influence: 6.4] [Reference Citation Analysis]
6 Brounais-le Royer B, Pierroz DD, Velin D, Frossard C, Zheng XX, Lehr H, Ferrari-lacraz S, Ferrari SL. Effects of an Interleukin-15 Antagonist on Systemic and Skeletal Alterations in Mice with DSS-Induced Colitis. The American Journal of Pathology 2013;182:2155-67. [DOI: 10.1016/j.ajpath.2013.02.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
7 Yamamoto-Furusho JK, Sánchez-Morales GE, García-Rangel D, Vargas-Alarcón G. Genetic polymorphisms of interleukin-22 in patients with ulcerative colitis. Rev Gastroenterol Mex 2016;81:86-90. [PMID: 26994530 DOI: 10.1016/j.rgmx.2016.02.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Szkaradkiewicz A, Marciniak R, Chudzicka-strugała I, Wasilewska A, Drews M, Majewski P, Karpiński T, Zwoździak B. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Arch Immunol Ther Exp 2009;57:291-4. [DOI: 10.1007/s00005-009-0031-z] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 5.6] [Reference Citation Analysis]
9 Bianchi ML. Inflammatory bowel diseases, celiac disease, and bone. Arch Biochem Biophys 2010;503:54-65. [PMID: 20599670 DOI: 10.1016/j.abb.2010.06.026] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 3.0] [Reference Citation Analysis]
10 Jones J, Panaccione R. Biologic therapy in Crohn's disease: state of the art. Curr Opin Gastroenterol. 2008;24:475-481. [PMID: 18622162 DOI: 10.1097/mog.0b013e3283043596] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
11 Yazbeck R, Howarth GS, Abbott CA. Growth factor based therapies and intestinal disease: is glucagon-like peptide-2 the new way forward? Cytokine Growth Factor Rev. 2009;20:175-184. [PMID: 19324585 DOI: 10.1016/j.cytogfr.2009.02.008] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
12 Johnsen KM, Goll R, Hansen V, Olsen T, Rismo R, Heitmann R, Gundersen MD, Kvamme JM, Paulssen EJ, Kileng H, Johnsen K, Florholmen J. Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm. Eur J Gastroenterol Hepatol 2017;29:98-104. [PMID: 27749779 DOI: 10.1097/MEG.0000000000000753] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
13 Busquets D, Mas-de-Xaxars T, López-Siles M, Martínez-Medina M, Bahí A, Sàbat M, Louvriex R, Miquel-Cusachs JO, Garcia-Gil JL, Aldeguer X. Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn's Disease. J Crohns Colitis 2015;9:899-906. [PMID: 26142465 DOI: 10.1093/ecco-jcc/jjv119] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 6.1] [Reference Citation Analysis]
14 Argollo M, Fiorino G, Hindryckx P, Peyrin-biroulet L, Danese S. Novel therapeutic targets for inflammatory bowel disease. Journal of Autoimmunity 2017;85:103-16. [DOI: 10.1016/j.jaut.2017.07.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 11.8] [Reference Citation Analysis]
15 Rismo R, Olsen T, Ciu G, Paulssen EJ, Christiansen I, Florholmen J, Goll R. The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease. Scandinavian Journal of Gastroenterology 2012;47:1200-10. [DOI: 10.3109/00365521.2012.711853] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wu SM, Xu DK, Zheng CQ. Expression of cluster of differentiation antigen-14 in intestinal mucosa of patients with inflammatory bowel disease and its implication. Shijie Huaren Xiaohua Zazhi 2009; 17(24): 2526-2529 [DOI: 10.11569/wcjd.v17.i24.2526] [Reference Citation Analysis]
17 Shih DQ, Michelsen KS, Barrett RJ, Biener-Ramanujan E, Gonsky R, Zhang X, Targan SR. Insights into TL1A and IBD pathogenesis. Adv Exp Med Biol. 2011;691:279-288. [PMID: 21153332 DOI: 10.1007/978-1-4419-6612-4_29] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
18 Hausmann J, Kubesch A, Amiri M, Filmann N, Blumenstein I. Vitamin D Deficiency is Associated with Increased Disease Activity in Patients with Inflammatory Bowel Disease. J Clin Med 2019;8:E1319. [PMID: 31461996 DOI: 10.3390/jcm8091319] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
19 Sugihara T, Kobori A, Imaeda H, Tsujikawa T, Amagase K, Takeuchi K, Fujiyama Y, Andoh A. The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease. Clin Exp Immunol. 2010;160:386-393. [PMID: 20089077 DOI: 10.1111/j.1365-2249.2010.04093.x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 5.5] [Reference Citation Analysis]
20 Wang GL, Yin JH, Mao DA, He F, Yin F. Tumor necrosis factor-α increases the paracellular permeability of Caco-2 cell monolayers in vitroShijie Huaren Xiaohua Zazhi 2010; 18(9): 942-946 [DOI: 10.11569/wcjd.v18.i9.942] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
21 Li J, Chen N, Wang D, Zhang J, Gong X. Efficacy of vitamin D in treatment of inflammatory bowel disease: A meta-analysis. Medicine (Baltimore) 2018;97:e12662. [PMID: 30431562 DOI: 10.1097/MD.0000000000012662] [Cited by in Crossref: 39] [Cited by in F6Publishing: 17] [Article Influence: 9.8] [Reference Citation Analysis]
22 Maden SF, Acuner SE. Mapping Transcriptome Data to Protein-Protein Interaction Networks of Inflammatory Bowel Diseases Reveals Disease-Specific Subnetworks. Front Genet 2021;12:688447. [PMID: 34484291 DOI: 10.3389/fgene.2021.688447] [Reference Citation Analysis]
23 Maul J, Zeitz M. Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations. Langenbecks Arch Surg. 2012;397:1-10. [PMID: 21479621 DOI: 10.1007/s00423-011-0789-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
24 Guan Q. A Comprehensive Review and Update on the Pathogenesis of Inflammatory Bowel Disease. J Immunol Res 2019;2019:7247238. [PMID: 31886308 DOI: 10.1155/2019/7247238] [Cited by in Crossref: 95] [Cited by in F6Publishing: 90] [Article Influence: 31.7] [Reference Citation Analysis]
25 Yu PL, Zhang XF, Shen FC, Zhang HJ. Association between interleukin-17 gene polymorphisms and inflammatory bowel disease in Chinese patients. Shijie Huaren Xiaohua Zazhi 2012; 20(10): 875-882 [DOI: 10.11569/wcjd.v20.i10.875] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
26 Baritaki S, de Bree E, Chatzaki E, Pothoulakis C. Chronic Stress, Inflammation, and Colon Cancer: A CRH System-Driven Molecular Crosstalk. J Clin Med 2019;8:E1669. [PMID: 31614860 DOI: 10.3390/jcm8101669] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
27 Chu ZX, Qin HL. Progress of gut associated lymphocyte homing in inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2009; 17(7): 687-693 [DOI: 10.11569/wcjd.v17.i7.687] [Reference Citation Analysis]
28 De la Fuente M, Franchi L, Araya D, Díaz-Jiménez D, Olivares M, Álvarez-Lobos M, Golenbock D, González MJ, López-Kostner F, Quera R, Núñez G, Vidal R, Hermoso MA. Escherichia coli isolates from inflammatory bowel diseases patients survive in macrophages and activate NLRP3 inflammasome. Int J Med Microbiol 2014;304:384-92. [PMID: 24581881 DOI: 10.1016/j.ijmm.2014.01.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
29 Monk JM, Jia Q, Callaway E, Weeks B, Alaniz RC, McMurray DN, Chapkin RS. Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice. J Nutr. 2012;142:117-124. [PMID: 22131549 DOI: 10.3945/jn.111.147058] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 4.3] [Reference Citation Analysis]
30 McConnell BB, Yang VW. The Role of Inflammation in the Pathogenesis of Colorectal Cancer. Curr Colorectal Cancer Rep. 2009;5:69-74. [PMID: 19756239 DOI: 10.1007/s11888-009-0011-z] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
31 Kiank C, Taché Y, Larauche M. Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors. Brain Behav Immun. 2010;24:41-48. [PMID: 19698778 DOI: 10.1016/j.bbi.2009.08.006] [Cited by in Crossref: 61] [Cited by in F6Publishing: 65] [Article Influence: 4.7] [Reference Citation Analysis]
32 Guan Q, Weiss CR, Wang S, Qing G, Yang X, Warrington RJ, Bernstein CN, Peng Z. Reversing Ongoing Chronic Intestinal Inflammation and Fibrosis by Sustained Block of IL-12 and IL-23 Using a Vaccine in Mice. Inflamm Bowel Dis 2018;24:1941-52. [PMID: 29788053 DOI: 10.1093/ibd/izy142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
33 Zhang H, Xia B, Li J, Zhao Q, Chen Z, Zhou R, Wu J. Expression and clinical significance of IL-17 and IL-17 receptor in ulcerative colitis. J Huazhong Univ Sci Technol [Med Sci ] 2016;36:37-40. [DOI: 10.1007/s11596-016-1538-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
34 Gilardi D, Fiorino G, Genua M, Allocca M, Danese S. Complementary and alternative medicine in inflammatory bowel diseases: what is the future in the field of herbal medicine? Expert Rev Gastroenterol Hepatol 2014;8:835-46. [PMID: 24813226 DOI: 10.1586/17474124.2014.917954] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
35 Pini M, Gove ME, Fayad R, Cabay RJ, Fantuzzi G. Adiponectin deficiency does not affect development and progression of spontaneous colitis in IL-10 knockout mice. Am J Physiol Gastrointest Liver Physiol. 2009;296:G382-G387. [PMID: 19074637 DOI: 10.1152/ajpgi.90593.2008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
36 Zhang F, Zhang XL, Liu D, Wang W, Liu JX. Advances in biological function of interleukin-21 and inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2008; 16(19): 2131-2136 [DOI: 10.11569/wcjd.v16.i19.2131] [Reference Citation Analysis]
37 Baumgart DC. What’s new in inflammatory bowel disease in 2008? World J Gastroenterol 2008; 14(3): 329-330 [PMID: 18200655 DOI: 10.3748/wjg.14.329] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
38 Del Pinto R, Pietropaoli D, Chandar AK, Ferri C, Cominelli F. Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2015;21:2708-2717. [PMID: 26348447 DOI: 10.1097/mib.0000000000000546] [Cited by in Crossref: 120] [Cited by in F6Publishing: 64] [Article Influence: 20.0] [Reference Citation Analysis]
39 Li H, Chen X, Liu J, Chen M, Huang M, Huang G, Chen X, Du Q, Su J, Lin R. Ethanol extract of Centella asiatica alleviated dextran sulfate sodium-induced colitis: Restoration on mucosa barrier and gut microbiota homeostasis. J Ethnopharmacol 2021;267:113445. [PMID: 33022343 DOI: 10.1016/j.jep.2020.113445] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Wyant T, Fedyk E, Abhyankar B. An Overview of the Mechanism of Action of the Monoclonal Antibody Vedolizumab. J Crohns Colitis. 2016;10:1437-1444. [PMID: 27252400 DOI: 10.1093/ecco-jcc/jjw092] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 13.5] [Reference Citation Analysis]
41 Actis GC, Rosina F, Mackay IR. Inflammatory bowel disease: beyond the boundaries of the bowel. Expert Rev Gastroenterol Hepatol 2011;5:401-10. [PMID: 21651357 DOI: 10.1586/egh.11.23] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
42 Zhang Y, Li F, Wang H, Yin C, Huang J, Mahavadi S, Murthy KS, Hu W. Immune/Inflammatory Response and Hypocontractility of Rabbit Colonic Smooth Muscle After TNBS-Induced Colitis. Dig Dis Sci 2016;61:1925-40. [PMID: 26879904 DOI: 10.1007/s10620-016-4078-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
43 Rismo R, Olsen T, Cui G, Christiansen I, Florholmen J, Goll R. Mucosal cytokine gene expression profiles as biomarkers of response to infliximab in ulcerative colitis. Scand J Gastroenterol. 2012;47:538-547. [PMID: 22486187 DOI: 10.3109/00365521.2012.667146] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
44 Yang L, Zheng PY, Liu ZQ. Effect of corticotropin-releasing factor on expression of tight junction proteins in intestinal epithelial cells. Shijie Huaren Xiaohua Zazhi 2013; 21(24): 2424-2428 [DOI: 10.11569/wcjd.v21.i24.2424] [Reference Citation Analysis]
45 Lin YH, Zhou P, Ma PE, Guo XQ, Xia TY, Shen BF, Li Y, Han GC. Expression of IL-17 in inflammatory bowel disease and synergistic action of IL-17 and LPS on IL-8 expression in intestinal epithelial cells. Shijie Huaren Xiaohua Zazhi 2012; 20(12): 991-997 [DOI: 10.11569/wcjd.v20.i12.991] [Reference Citation Analysis]
46 Berg DR, Colombel JF, Ungaro R. The Role of Early Biologic Therapy in Inflammatory Bowel Disease. Inflamm Bowel Dis 2019;25:1896-905. [PMID: 30934053 DOI: 10.1093/ibd/izz059] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
47 Xiong J, Zhou MF, Wang YD, Chen LP, Xu WF, Wang YD, Deng F, Liu SD. Protein Kinase D2 Protects against Acute Colitis Induced by Dextran Sulfate Sodium in Mice. Sci Rep 2016;6:34079. [PMID: 27659202 DOI: 10.1038/srep34079] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
48 Pinho M. A Biologia molecular das doenças inflamatórias intestinais. Rev bras colo-proctol 2008;28:119-23. [DOI: 10.1590/s0101-98802008000100018] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
49 Ortuño Sahagún D, Márquez-Aguirre AL, Quintero-Fabián S, López-Roa RI, Rojas-Mayorquín AE. Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases. PPAR Res 2012;2012:318613. [PMID: 23251142 DOI: 10.1155/2012/318613] [Cited by in Crossref: 24] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
50 Hwang J, Jin J, Jeon S, Moon SH, Park MY, Yum DY, Kim JH, Kang JE, Park MH, Kim EJ, Pan JG, Kwon O, Oh GT. SOD1 suppresses pro-inflammatory immune responses by protecting against oxidative stress in colitis. Redox Biol 2020;37:101760. [PMID: 33096425 DOI: 10.1016/j.redox.2020.101760] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
51 Shin JM, Son Y, Ha IJ, Erdenebileg S, Jung DS, Song D, Kim YS, Kim SM, Nho CW. Artemisia argyi extract alleviates inflammation in a DSS-induced colitis mouse model and enhances immunomodulatory effects in lymphoid tissues. BMC Complement Med Ther 2022;22. [DOI: 10.1186/s12906-022-03536-x] [Reference Citation Analysis]
52 Török H, Göke B, Konrad A. Pharmacogenetics of Crohn’s disease. Pharmacogenomics 2008;9:881-93. [DOI: 10.2217/14622416.9.7.881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
53 Haritunians T, Jones MR, McGovern DP, Shih DQ, Barrett RJ, Derkowski C, Dubinsky MC, Dutridge D, Fleshner PR, Ippoliti A. Variants in ZNF365 isoform D are associated with Crohn's disease. Gut. 2011;60:1060-1067. [PMID: 21257989 DOI: 10.1136/gut.2010.227256] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
54 Hoffman-goetz L, Pervaiz N, Packer N, Guan J. Freewheel training decreases pro- and increases anti-inflammatory cytokine expression in mouse intestinal lymphocytes. Brain, Behavior, and Immunity 2010;24:1105-15. [DOI: 10.1016/j.bbi.2010.05.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
55 Xue NN, He M, Li Y, Wu JZ, Du WW, Wu XM, Yang ZZ, Zhang CG, Li QY, Xiao H. Periplaneta americana extract promotes intestinal mucosa repair of ulcerative colitis in rat. Acta Cir Bras 2020;35:e202001002. [PMID: 33237174 DOI: 10.1590/s0102-865020200100000002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Marjara IS, Chikwati EM, Valen EC, Krogdahl Å, Bakke AM. Transcriptional regulation of IL-17A and other inflammatory markers during the development of soybean meal-induced enteropathy in the distal intestine of Atlantic salmon (Salmo salar L.). Cytokine 2012;60:186-96. [DOI: 10.1016/j.cyto.2012.05.027] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 8.7] [Reference Citation Analysis]
57 Pearl DS, Shah K, Whittaker MA, Nitch-Smith H, Brown JF, Shute JK, Trebble TM. Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity. J Crohns Colitis. 2013;7:481-489. [PMID: 22974822 DOI: 10.1016/j.crohns.2012.07.022] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
58 Godoi DF, Cardoso CR, Ferraz DB, Provinciatto PR, Cunha FQ, Silva JS, Voltarelli JC. Hematopoietic SCT modulates gut inflammation in experimental inflammatory bowel disease. Bone Marrow Transplant. 2010;45:1562-1571. [PMID: 20228850 DOI: 10.1038/bmt.2010.6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
59 Hu W, Li F, Mahavadi S, Murthy KS. Upregulation of RGS4 expression by IL-1beta in colonic smooth muscle is enhanced by ERK1/2 and p38 MAPK and inhibited by the PI3K/Akt/GSK3beta pathway. Am J Physiol Cell Physiol. 2009;296:C1310-C1320. [PMID: 19369446 DOI: 10.1152/ajpcell.00573.2008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 2.8] [Reference Citation Analysis]
60 Monk JM, Turk HF, Fan YY, Callaway E, Weeks B, Yang P, McMurray DN, Chapkin RS. Antagonizing arachidonic acid-derived eicosanoids reduces inflammatory Th17 and Th1 cell-mediated inflammation and colitis severity. Mediators Inflamm 2014;2014:917149. [PMID: 25136149 DOI: 10.1155/2014/917149] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
61 Arya VS, Kanthlal SK, Linda G. The role of dietary polyphenols in inflammatory bowel disease: A possible clue on the molecular mechanisms involved in the prevention of immune and inflammatory reactions. J Food Biochem 2020;44:e13369. [PMID: 32885438 DOI: 10.1111/jfbc.13369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
62 Jin NS, Dong Z, Fu JM, Zeng FX. DPP-4 inhibitors and inflammatory bowel disease. Shijie Huaren Xiaohua Zazhi 2010; 18(30): 3215-3219 [DOI: 10.11569/wcjd.v18.i30.3215] [Reference Citation Analysis]
63 Sun W, Lirio RA, Schneider J, Aubrecht J, Kadali H, Baratta M, Gulati P, Suri A, Lin T, Vasudevan R, Rosario M. Assessment of Vedolizumab Disease-Drug-Drug Interaction Potential in Patients With Inflammatory Bowel Diseases. Clin Pharmacol Drug Dev 2021;10:734-47. [PMID: 33331142 DOI: 10.1002/cpdd.891] [Reference Citation Analysis]
64 Waterman M, Xu W, Stempak JM, Milgrom R, Bernstein CN, Griffiths AM, Greenberg GR, Steinhart AH, Silverberg MS. Distinct and overlapping genetic loci in Crohn’s disease and ulcerative colitis: correlations with pathogenesis. Inflamm Bowel Dis. 2011;17:1936-1942. [PMID: 21830272 DOI: 10.1002/ibd.21579] [Cited by in Crossref: 77] [Cited by in F6Publishing: 79] [Article Influence: 6.4] [Reference Citation Analysis]
65 Yamaguchi M, Yahagi N, Kato H, Takano F, Ohta T. Capsicum extract and its constituents modulated the production of immunoglobulins in Peyer’s patch cells ex vivo. Journal of Functional Foods 2010;2:255-62. [DOI: 10.1016/j.jff.2010.09.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
66 Silva FA, Rodrigues BL, Ayrizono ML, Leal RF. The Immunological Basis of Inflammatory Bowel Disease. Gastroenterol Res Pract. 2016;2016:2097274. [PMID: 28070181 DOI: 10.1155/2016/2097274] [Cited by in Crossref: 51] [Cited by in F6Publishing: 46] [Article Influence: 8.5] [Reference Citation Analysis]
67 Liu ZJ, Yadav PK, Su JL, Wang JS, Fei K. Potential role of Th17 cells in the pathogenesis of inflammatory bowel disease. World J Gastroenterol 2009; 15(46): 5784-5788 [PMID: 19998498 DOI: 10.3748/wjg.15.5784] [Cited by in CrossRef: 97] [Cited by in F6Publishing: 101] [Article Influence: 7.5] [Reference Citation Analysis]
68 Coquet-Reinier B, Berdah SV, Grimaud JC, Birnbaum D, Cougard PA, Barthet M, Desjeux A, Moutardier V, Brunet C. Preoperative infliximab treatment and postoperative complications after laparoscopic restorative proctocolectomy with ileal pouch-anal anastomosis: a case-matched study. Surg Endosc. 2010;24:1866-1871. [PMID: 20108148 DOI: 10.1007/s00464-009-0861-0] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 4.3] [Reference Citation Analysis]
69 Capoccia E, Cirillo C, Gigli S, Pesce M, D’alessandro A, Cuomo R, Sarnelli G, Steardo L, Esposito G. Enteric glia: A new player in inflammatory bowel diseases. Int J Immunopathol Pharmacol 2015;28:443-51. [DOI: 10.1177/0394632015599707] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.4] [Reference Citation Analysis]
70 Cohavy O, Shih DQ, Doherty TM, Ware CF, Targan SR. CD161 DEFINES EFFECTOR T CELLS THAT EXPRESS LIGHT AND RESPOND TO TL1A-DR3 SIGNALING. Eur J Microbiol Immunol (Bp) 2011;1:70-9. [PMID: 22348196 DOI: 10.1556/EuJMI.1.2011.1.9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
71 Jatoi I, Benson JR, Liau SS, Chen Y, Cisco RM, Norton JA, Moley JF, Khalifeh KW, Choti MA. The role of surgery in cancer prevention. Curr Probl Surg 2010;47:750-830. [PMID: 20816140 DOI: 10.1067/j.cpsurg.2010.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
72 Rismo R, Olsen T, Cui G, Paulssen EJ, Christiansen I, Johnsen K, Florholmen J, Goll R. Normalization of mucosal cytokine gene expression levels predicts long-term remission after discontinuation of anti-TNF therapy in Crohn’s disease. Scand J Gastroenterol. 2013;48:311-319. [PMID: 23302000 DOI: 10.3109/00365521.2012.758773] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
73 Gentschew L, Ferguson LR. Role of nutrition and microbiota in susceptibility to inflammatory bowel diseases. Mol Nutr Food Res. 2012;56:524-535. [PMID: 22495981 DOI: 10.1002/mnfr.201100630] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 9.1] [Reference Citation Analysis]
74 Mimura S, Ando T, Ishiguro K, Maeda O, Watanabe O, Ujihara M, Hirayama Y, Morise K, Maeda K, Matsushita M, Funasaka K, Nakamura M, Miyahara R, Ozaki N, Goto H. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis. Scand J Gastroenterol 2013;48:1152-9. [PMID: 24047394 DOI: 10.3109/00365521.2013.832366] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.9] [Reference Citation Analysis]
75 Wang Y, Wang W, Yang H, Shao D, Zhao X, Zhang G. Intraperitoneal injection of 4-hydroxynonenal (4-HNE), a lipid peroxidation product, exacerbates colonic inflammation through activation of Toll-like receptor 4 signaling. Free Radic Biol Med 2019;131:237-42. [PMID: 30503401 DOI: 10.1016/j.freeradbiomed.2018.11.037] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
76 Pacheco MT, Vezza T, Diez-echave P, Utrilla P, Villamiel M, Moreno FJ. Anti-inflammatory bowel effect of industrial orange by-products in DSS-treated mice. Food Funct 2018;9:4888-96. [DOI: 10.1039/c8fo01060a] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 4.3] [Reference Citation Analysis]
77 Heidarian F, Noormohammadi Z, Asadzadeh Aghdaei H, Alebouyeh M. Relative Abundance of Streptococcus spp. and its Association with Disease Activity in Inflammatory Bowel Disease Patients Compared with Controls. Arch Clin Infect Dis 2017;In Press. [DOI: 10.5812/archcid.57291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
78 Iwaya H, Lee JS, Yamagishi S, Shinoki A, Lang W, Thawornkuno C, Kang HK, Kumagai Y, Suzuki S, Kitamura S, Hara H, Okuyama M, Mori H, Kimura A, Ishizuka S. The delay in the development of experimental colitis from isomaltosyloligosaccharides in rats is dependent on the degree of polymerization. PLoS One 2012;7:e50658. [PMID: 23209802 DOI: 10.1371/journal.pone.0050658] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
79 Collado MC, Isolauri E, Laitinen K, Salminen S. Effect of mother’s weight on infant’s microbiota acquisition, composition, and activity during early infancy: a prospective follow-up study initiated in early pregnancy. Am J Clin Nutr. 2010;92:1023-1030. [PMID: 20844065 DOI: 10.3945/ajcn.2010.29877] [Cited by in Crossref: 207] [Cited by in F6Publishing: 177] [Article Influence: 17.3] [Reference Citation Analysis]
80 Smole A, Lainšček D, Bezeljak U, Horvat S, Jerala R. A Synthetic Mammalian Therapeutic Gene Circuit for Sensing and Suppressing Inflammation. Mol Ther 2017;25:102-19. [PMID: 28129106 DOI: 10.1016/j.ymthe.2016.10.005] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
81 Zhang W, Heng J, Kim SW, Chen F, Deng Z, Zhang S, Guan W. Dietary enzymatically-treated Artemisia annua L. supplementation could alleviate oxidative injury and improve reproductive performance of sows reared under high ambient temperature. J Therm Biol 2020;94:102751. [PMID: 33292992 DOI: 10.1016/j.jtherbio.2020.102751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Pascoal LB, Palma BB, Chaim FHM, de Castro MM, Damázio TA, Franceschini APMF, Milanski M, Velloso LA, Leal RF. New translational and experimental insights into the role of pro-resolving lipid mediators in inflammatory bowel disease. World J Exp Med 2022; 12(1): 1-15 [DOI: 10.5493/wjem.v12.i1.1] [Reference Citation Analysis]
83 Kim HY, Jeon H, Bae CH, Lee Y, Kim H, Kim S. Rumex japonicus Houtt. alleviates dextran sulfate sodium-induced colitis by protecting tight junctions in mice. Integr Med Res 2020;9:100398. [PMID: 32322483 DOI: 10.1016/j.imr.2020.02.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
84 Takeda S, Sato T, Katsuno T, Nakagawa T, Noguchi Y, Yokosuka O, Saito Y. Adsorptive depletion of alpha4 integrin(hi)- and CX3CR1hi-expressing proinflammatory monocytes in patients with ulcerative colitis. Dig Dis Sci. 2010;55:1886-1895. [PMID: 19908144 DOI: 10.1007/s10620-009-0974-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
85 Kim SE, Kawaguchi K, Hayashi H, Furusho K, Maruyama M. Remission Effects of Dietary Soybean Isoflavones on DSS-Induced Murine Colitis and an LPS-Activated Macrophage Cell Line. Nutrients. 2019;11. [PMID: 31362418 DOI: 10.3390/nu11081746] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
86 Guan Q, Ma Y, Hillman CL, Qing G, Ma AG, Weiss CR, Zhou G, Bai A, Warrington RJ, Bernstein CN. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis. Mol Med. 2011;17:646-656. [PMID: 21424108 DOI: 10.2119/molmed.2010.00252] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 2.5] [Reference Citation Analysis]
87 Van Domselaar M, López San Román A, Bastos Oreiro M, Garrido Gómez E. [Lymphoproliferative disorders in an inflammatory bowel disease unit]. Gastroenterol Hepatol 2010;33:12-6. [PMID: 19889478 DOI: 10.1016/j.gastrohep.2009.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
88 Grześkowiak Ł, Collado MC, Mangani C, Maleta K, Laitinen K, Ashorn P, Isolauri E, Salminen S. Distinct gut microbiota in southeastern African and northern European infants. J Pediatr Gastroenterol Nutr 2012;54:812-6. [PMID: 22228076 DOI: 10.1097/MPG.0b013e318249039c] [Cited by in Crossref: 90] [Cited by in F6Publishing: 52] [Article Influence: 9.0] [Reference Citation Analysis]
89 Maul J, Zeitz M. Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations. Langenbecks Arch Surg. 2012;397:1-10. [PMID: 21479621 DOI: 10.1007/s00423-011-0789-4.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Erdogan Kayhan G, Gul M, Kayhan B, Gedik E, Ozgul U, Kurtoglu EL, Durmus M, Ersoy MÖ. Dexmedetomidine ameliorates TNBS-induced colitis by inducing immunomodulator effect. J Surg Res 2013;183:733-41. [PMID: 23582761 DOI: 10.1016/j.jss.2013.03.028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
91 Pagoldh M, Hultgren E, Arnell P, Eriksson A. Hyperbaric oxygen therapy does not improve the effects of standardized treatment in a severe attack of ulcerative colitis: a prospective randomized study. Scandinavian Journal of Gastroenterology 2013;48:1033-40. [DOI: 10.3109/00365521.2013.819443] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
92 Jones-Hall YL, Grisham MB. Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease. Pathophysiology. 2014;21:267-288. [PMID: 24935242 DOI: 10.1016/j.pathophys.2014.05.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
93 Monk JM, Hou TY, Turk HF, Weeks B, Wu C, McMurray DN, Chapkin RS. Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated inflammation during colitis. PLoS One. 2012;7:e49739. [PMID: 23166761 DOI: 10.1371/journal.pone.0049739] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 5.9] [Reference Citation Analysis]
94 Zhang JX, Wang K, Mao ZF, Fan X, Jiang DL, Chen M, Cui L, Sun K, Dang SC. Application of liposomes in drug development--focus on gastroenterological targets. Int J Nanomedicine. 2013;8:1325-1334. [PMID: 23630417 DOI: 10.2147/ijn.s42153] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
95 Ba Neville, Pw O’toole. Probiotic properties of Lactobacillus salivarius and closely related Lactobacillus species. Future Microbiology 2010;5:759-74. [DOI: 10.2217/fmb.10.35] [Cited by in Crossref: 72] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
96 Roblin X, Pillet S, Oussalah A, Berthelot P, Del Tedesco E, Phelip J, Chambonnière M, Garraud O, Peyrin-biroulet L, Pozzetto B. Cytomegalovirus Load in Inflamed Intestinal Tissue Is Predictive of Resistance to Immunosuppressive Therapy in Ulcerative Colitis. American Journal of Gastroenterology 2011;106:2001-8. [DOI: 10.1038/ajg.2011.202] [Cited by in Crossref: 106] [Cited by in F6Publishing: 108] [Article Influence: 9.6] [Reference Citation Analysis]
97 Teixeira LG, Leonel AJ, Aguilar EC, Batista NV, Alves AC, Coimbra CC, Ferreira AV, de Faria AM, Cara DC, Alvarez Leite JI. The combination of high-fat diet-induced obesity and chronic ulcerative colitis reciprocally exacerbates adipose tissue and colon inflammation. Lipids Health Dis. 2011;10:204. [PMID: 22073943 DOI: 10.1186/1476-511x-10-204] [Cited by in Crossref: 56] [Cited by in F6Publishing: 29] [Article Influence: 5.1] [Reference Citation Analysis]
98 Zhu G, Wang H, Wang T, Shi F. Ginsenoside Rg1 attenuates the inflammatory response in DSS-induced mice colitis. Int Immunopharmacol. 2017;50:1-5. [PMID: 28605639 DOI: 10.1016/j.intimp.2017.06.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 4.6] [Reference Citation Analysis]
99 Han YM, Koh J, Kim JW, Lee C, Koh SJ, Kim B, Lee KL, Im JP, Kim JS. NF-kappa B activation correlates with disease phenotype in Crohn's disease. PLoS One 2017;12:e0182071. [PMID: 28753650 DOI: 10.1371/journal.pone.0182071] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
100 Hong JY, Chung KS, Shin JS, Park G, Jang YP, Lee KT. Anti-Colitic Effects of Ethanol Extract of Persea americana Mill. through Suppression of Pro-Inflammatory Mediators via NF-κB/STAT3 Inactivation in Dextran Sulfate Sodium-Induced Colitis Mice. Int J Mol Sci 2019;20:E177. [PMID: 30621304 DOI: 10.3390/ijms20010177] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
101 Iacomino G, Rotondi Aufiero V, Iannaccone N, Melina R, Giardullo N, De Chiara G, Venezia A, Taccone FS, Iaquinto G, Mazzarella G. IBD: Role of intestinal compartments in the mucosal immune response. Immunobiology 2020;225:151849. [PMID: 31563276 DOI: 10.1016/j.imbio.2019.09.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
102 Gómez-gallego C, Collado MC, Ilo T, Jaakkola U, Bernal MJ, Periago MJ, Salminen S, Ros G, Frias R. Infant formula supplemented with polyamines alters the intestinal microbiota in neonatal BALB/cOlaHsd mice. The Journal of Nutritional Biochemistry 2012;23:1508-13. [DOI: 10.1016/j.jnutbio.2011.10.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
103 Shih DQ, Targan SR, McGovern D. Recent advances in IBD pathogenesis: genetics and immunobiology. Curr Gastroenterol Rep. 2008;10:568-575. [PMID: 19006613 DOI: 10.1007/s11894-008-0104-x] [Cited by in Crossref: 68] [Cited by in F6Publishing: 71] [Article Influence: 5.2] [Reference Citation Analysis]
104 Shih DQ, Kwan LY, Chavez V, Cohavy O, Gonsky R, Chang EY, Chang C, Elson CO, Targan SR. Microbial induction of inflammatory bowel disease associated gene TL1A (TNFSF15) in antigen presenting cells. Eur J Immunol 2009;39:3239-50. [PMID: 19839006 DOI: 10.1002/eji.200839087] [Cited by in Crossref: 62] [Cited by in F6Publishing: 63] [Article Influence: 5.2] [Reference Citation Analysis]
105 Melmed GY, Targan SR. Future biologic targets for IBD: potentials and pitfalls. Nat Rev Gastroenterol Hepatol. 2010;7:110-117. [PMID: 20134493 DOI: 10.1038/nrgastro.2009.218] [Cited by in Crossref: 58] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
106 Shih DQ, Targan SR. Insights into IBD Pathogenesis. Curr Gastroenterol Rep. 2009;11:473-480. [PMID: 19903423 DOI: 10.1007/s11894-009-0072-9] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 4.7] [Reference Citation Analysis]
107 D’Alessio S, Correale C, Tacconi C, Gandelli A, Pietrogrande G, Vetrano S, Genua M, Arena V, Spinelli A, Peyrin-Biroulet L. VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease. J Clin Invest. 2014;124:3863-3878. [PMID: 25105363 DOI: 10.1172/jci72189] [Cited by in Crossref: 136] [Cited by in F6Publishing: 84] [Article Influence: 17.0] [Reference Citation Analysis]
108 Giles DA, Zahner S, Krause P, Van Der Gracht E, Riffelmacher T, Morris V, Tumanov A, Kronenberg M. The Tumor Necrosis Factor Superfamily Members TNFSF14 (LIGHT), Lymphotoxin β and Lymphotoxin β Receptor Interact to Regulate Intestinal Inflammation. Front Immunol 2018;9:2585. [PMID: 30524422 DOI: 10.3389/fimmu.2018.02585] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
109 Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, Moris F, Rodrigo L, Mira A, Collado MC. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 2015;50:167-79. [PMID: 24811328 DOI: 10.1007/s00535-014-0963-x] [Cited by in Crossref: 128] [Cited by in F6Publishing: 124] [Article Influence: 16.0] [Reference Citation Analysis]
110 Guan Q, Ma Y, Hillman CL, Ma A, Zhou G, Qing G, Peng Z. Development of recombinant vaccines against IL-12/IL-23 p40 and in vivo evaluation of their effects in the downregulation of intestinal inflammation in murine colitis. Vaccine 2009;27:7096-104. [PMID: 19786142 DOI: 10.1016/j.vaccine.2009.09.058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
111 Lee IA, Kim DH. Klebsiella pneumoniae increases the risk of inflammation and colitis in a murine model of intestinal bowel disease. Scand J Gastroenterol. 2011;46:684-693. [PMID: 21410316 DOI: 10.3109/00365521.2011.560678] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
112 Dige A, Magnusson MK, Uhrenholt C, Rasmussen TK, Kragstrup T, Öhman L, Dahlerup J, Agnholt J. Effects of Anti-TNFα Treatment on Mucosal Expression of IL-17A, IL-21, and IL-22 and Cytokine-Producing T Cell Subsets in Crohn's Disease. Mediators Inflamm 2018;2018:3279607. [PMID: 29853788 DOI: 10.1155/2018/3279607] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
113 Kontaki E, Boumpas DT, Tzardi M, Mouzas IA, Papadakis KA, Verginis P. Aberrant function of myeloid-derived suppressor cells (MDSCs) in experimental colitis and in inflammatory bowel disease (IBD) immune responses. Autoimmunity 2017;50:170-81. [PMID: 28276713 DOI: 10.1080/08916934.2017.1283405] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
114 Øyri SF, Műzes G, Sipos F. Dysbiotic gut microbiome: A key element of Crohn's disease. Comp Immunol Microbiol Infect Dis 2015;43:36-49. [PMID: 26616659 DOI: 10.1016/j.cimid.2015.10.005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
115 Aboura I, Nani A, Belarbi M, Murtaza B, Fluckiger A, Dumont A, Benammar C, Tounsi MS, Ghiringhelli F, Rialland M, Khan NA, Hichami A. Protective effects of polyphenol-rich infusions from carob (Ceratonia siliqua) leaves and cladodes of Opuntia ficus-indica against inflammation associated with diet-induced obesity and DSS-induced colitis in Swiss mice. Biomed Pharmacother 2017;96:1022-35. [PMID: 29221725 DOI: 10.1016/j.biopha.2017.11.125] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
116 Kridin K, Zelber-sagi S, Comaneshter D, Cohen AD. Ulcerative colitis associated with pemphigus: a population-based large-scale study. Scandinavian Journal of Gastroenterology 2017;52:1360-4. [DOI: 10.1080/00365521.2017.1380839] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
117 Aktunc E, Kayhan B, Arasli M, Gun BD, Barut F. The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. Immunopharmacol Immunotoxicol 2011;33:667-75. [PMID: 21428710 DOI: 10.3109/08923973.2011.559475] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
118 Harsløf LB, Damsgaard CT, Andersen AD, Aakjær DL, Michaelsen KF, Hellgren LI, Frøkiær H, Vogel U, Lauritzen L. Reduced ex vivo stimulated IL-6 response in infants randomized to fish oil from 9 to 18 months, especially among PPARG2 and COX2 wild types. Prostaglandins, Leukotrienes and Essential Fatty Acids 2015;94:21-7. [DOI: 10.1016/j.plefa.2014.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
119 Barbosa T, Rescigno M. Host-bacteria interactions in the intestine: homeostasis to chronic inflammation. Wiley Interdiscip Rev Syst Biol Med. 2010;2:80-97. [PMID: 20836012 DOI: 10.1002/wsbm.48] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
120 Pothoulakis C. Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Aliment Pharmacol Ther 2009;30:826-33. [PMID: 19706150 DOI: 10.1111/j.1365-2036.2009.04102.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 77] [Article Influence: 5.7] [Reference Citation Analysis]
121 Okan G, Vural P, Peker O, Colakoglu E, Saruc M. Azathioprine-induced liver injury in a patient with multiple autoimmune syndrome. Journal of Dermatological Treatment 2010;21:357-60. [DOI: 10.3109/09546630903410174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]